Boulevard prices by the address. We price by the account.

It is a sensible model for a salon group. Open a sixth location, hire eight more stylists, pay for a sixth licence. Revenue and cost scale together and nobody feels hard done by.

Medical aesthetics does not always grow that way. A clinic often adds a nurse injector before it adds a room, or opens a small second site that does two days a week. Under Boulevard's pricing that second site pays the same as the flagship from the day it opens, which is exactly when it can least afford it.

Our Team Practice plan covers 10 practitioners at the main location, and each further location is $49 a month with 3 more practitioners included. If your second location is one nurse and a treatment chair, it costs you $49, not a second flagship subscription.

Boulevard came out of the salon world and it shows in the best way at the front desk. It also shows in what the chart can do. Notes are notes. Product inventory counts retail units.

If you inject, the chart is a legal document and the inventory is a recall liability. Those two facts drive most of what Zdrovia is. A vial gets received with its lot number and expiry, gets dispensed into a specific patient at a specific visit, and shows up on the invoice line. When a manufacturer issues a recall you run one query instead of reading through a year of appointments.

Charting works the same way. Fields are structured rather than free text, so a pain score or a unit count you record today can be plotted against the same measure next spring. The AI scribe listens to the appointment and writes into those fields, so dictating a note populates your data instead of producing another paragraph nobody will query.

Enterprise software tends to arrive with a demo call, a proposal and an annual term. There is nothing sinister about that, but it does mean you commit before you have used the thing in anger.

You can open Zdrovia right now and chart a real patient this afternoon. The free plan is the whole product rather than a crippled preview, funded by an all-in 4% on the card payments you process through us. If you decide we are wrong for you, you close the tab and your Stripe account carries on as it was.